InterOcean Capital Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$28.6M Buy
358,820
+113,434
+46% +$8.66M 0.68% 43
2023
Q4
$19.4M Buy
245,386
+120,327
+96% +$8.56M 0.52% 51
2023
Q3
$8.73M Buy
125,059
+116,813
+1,417% +$8.28M 0.27% 78
2023
Q2
$570K Sell
8,246
-7,040
-46% -$501K 0.02% 252
2023
Q1
$1.14M Buy
15,286
+8,167
+115% +$685K 0.04% 167
2022
Q4
$663K Sell
7,119
-709
-9% -$68.4K 0.02% 222
2022
Q3
$747K Sell
7,828
-1,508
-16% -$149K 0.03% 190
2022
Q2
$865K Buy
+9,336
New +$911K 0.04% 178

Other funds holding CVS

InterOcean Capital Group's CVS Position: Q1 2024 in Review

InterOcean Capital Group increased its CVS Health (CVS) stake by 46% in Q1 2024, buying an estimated $8.66M and bringing the position to 358,820 shares worth $28.6M. The position accounts for 0.68% of the portfolio, ranked #43.

InterOcean Capital Group first reported a position in CVS in Q2 2022 and has held it in 8 quarters since. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • InterOcean Capital Group held 358,820 shares of CVS Health worth $28.6M as of Q1 2024.
  • InterOcean Capital Group bought 113,434 CVS Health shares in Q1 2024, an estimated $8.66M.
  • CVS Health made up 0.68% of InterOcean Capital Group's portfolio in Q1 2024, its #43 holding.
  • InterOcean Capital Group first reported a position in CVS Health in Q2 2022 and has held it in 8 quarters since.
  • 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.